Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2024-01-08 00:00:00 ET · period of report 2024-01-04 · accession 0001628280-24-000867 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-08 | 2024-01-04 | ARWR | Oliver Tracie | Chief Commercial Off | A - Grant | $0.00 | +75.0K | 136.6K | +122% | $0 | |
| 2024-01-08 | 2024-01-05 | ARWR | Oliver Tracie | Chief Commercial Off | S - Sale | $33.89 | -74 | 136.5K | -0.1% | -$2,508 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-04 | A | A | 75,000 | $0.00 | 136,575 | D | — | — | (F1) Represents shares underlying restricted stock units with a grant date 01/04/24, which will vest in four equal annual installments. |
| 2 | Common | Common Stock | 2024-01-05 | S | D | 74 | $33.89 | 136,501 | D | — | — | (F3) Partial disposition of RSUs to satisfy tax withholding obligations. (F4) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. |